TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 8169616

Group type: EXPERIMENTAL
Intervention: High-dose nicardipine (0.15 mg/kg/hr)
Number of subjects: 365

Group type: COMPARATOR
Intervention: Low-dose nicardipine (0.075 mg/kg/hr)
Number of subjects: 365

Group type: EXPERIMENTAL
Intervention: High-dose nicardipine
Number of subjects: 365

Group type: COMPARATOR
Intervention: Low-dose nicardipine
Number of subjects: 365
Study: 3154680

Group type: EXPERIMENTAL
Intervention: Nisoldipine
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 30115326

Group type: EXPERIMENTAL
Intervention: Claroideoglomus etunicatum
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Gigaspora albida
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: C. etunicatum + G. albida
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control not inoculated
Number of subjects: 0
Study: 27665372

Group type: EXPERIMENTAL
Intervention: Tight control (target diastolic blood pressure, 85mmHg)
Number of subjects: 911

Group type: COMPARATOR
Intervention: Less tight control (target diastolic blood pressure, 100mmHg)
Number of subjects: 911

Group type: EXPERIMENTAL
Intervention: Tight control
Number of subjects: 911
Study: 25703857

Group type: EXPERIMENTAL
Intervention: Individualised intervention programme delivered by a psychologist
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard support (Control)
Number of subjects: 40
Study: 24072034

Group type: EXPERIMENTAL
Intervention: Progressive resistance training (PRT) for 7 weeks, performed 3 days/week.
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Acute resistance exercise (ARE) at 60% of 1-RM for three sets of 8-12 repetitions.
Number of subjects: 26
Study: 20538119

Group type: EXPERIMENTAL
Intervention: Residual thrombus score > or = 3
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Larger postprocedural reference vessel diameter
Number of subjects: 91
Study: 17879117

Group type: EXPERIMENTAL
Intervention: Delayed completion axillary lymph node dissection (two-step ALND)
Number of subjects: 179

Group type: COMPARATOR
Intervention: Immediate axillary lymph node dissection (one-step ALND)
Number of subjects: 179
Study: 16374169

Group type: EXPERIMENTAL
Intervention: Simulation-based learning (SIM)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Problem-based learning (PBL)
Number of subjects: 31
Study: 12846775

Group type: EXPERIMENTAL
Intervention: Protein-leaking dialyzers (BK-F series; Toray, Japan) for 6 months
Number of subjects: 13

Group type: COMPARATOR
Intervention: Conventional non-protein-leaking dialyzers
Number of subjects: 13
Study: 11039202

Group type: EXPERIMENTAL
Intervention: IFN a-2 monotherapy (10 million I.U. in 50 ml physiological saline)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: IFN a-2 + Farmarubicin (FRC) combination (50 mg in 50 ml physiological saline)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: IFN a-2 monotherapy and IFN a-2 + FRC combination (Group I + II)
Number of subjects: 33

Group type: COMPARATOR
Intervention: No treatment (Control Group III)
Number of subjects: 33
Study: 8657529

Group type: EXPERIMENTAL
Intervention: Albendazole
Number of subjects: 228

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 228
Study: 1603897

Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Alprazolam
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 3932142

Group type: EXPERIMENTAL
Intervention: Laser treatment
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Cryosurgery
Number of subjects: 106
Study: 31523892

Group type: EXPERIMENTAL
Intervention: Neladenoson bialanate (5, 10, 20, 30, and 40 mg)
Number of subjects: 462

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 462

Group type: EXPERIMENTAL
Intervention: Neladenoson bialanate
Number of subjects: 462
Study: 29313134

Group type: EXPERIMENTAL
Intervention: Zataria multiflora (ZM) extract mouthwash
Number of subjects: 63

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63
Study: 27776504

Group type: EXPERIMENTAL
Intervention: SoCog Mental‐State Reasoning Training (SoCog‐MSRT)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: SoCog Emotion Recognition Training (SoCog‐ERT)
Number of subjects: 31
Study: 25332327

Group type: EXPERIMENTAL
Intervention: Micronutrient supplementation
Number of subjects: 403

Group type: EXPERIMENTAL
Intervention: Zinc supplementation
Number of subjects: 403

Group type: EXPERIMENTAL
Intervention: Micronutrients without zinc
Number of subjects: 403

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 403
Study: 21817091

Group type: EXPERIMENTAL
Intervention: Probabilistic learning task
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Functional connectivity between the ventral striatum and the medial prefrontal cortex
Number of subjects: 67
Study: 19967441

Group type: EXPERIMENTAL
Intervention: Cognitive behavioral treatment (CBT)
Number of subjects: 27
Study: 18044259

Group type: EXPERIMENTAL
Intervention: 1 g ascorbic acid
Number of subjects: 143

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: Not applicable
Number of subjects: 143
Study: 16061568

Group type: EXPERIMENTAL
Intervention: Broselow cart
Number of subjects: 21

Group type: COMPARATOR
Intervention: Standard cart
Number of subjects: 21
Study: 11875333

Group type: EXPERIMENTAL
Intervention: Transdermal estradiol (0.025 mg/day) and norethisterone acetate (0.125 mg/day)
Number of subjects: 266
Study: 10435260

Group type: EXPERIMENTAL
Intervention: Standard program (longer inpatient treatment)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Abbreviated Inpatient program (shorter inpatient treatment)
Number of subjects: 0
Study: 7787134

Group type: EXPERIMENTAL
Intervention: Furosemide controlled release formulation (FR) with breakfast
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Furosemide controlled release formulation (LR) with breakfast
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Furosemide controlled release formulation (FR) fasting
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Furosemide controlled release formulation (LR) fasting
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Total furosemide absorbed
Number of subjects: 28
Study: 2186825

Group type: EXPERIMENTAL
Intervention: Preterm formula in trial A
Number of subjects: 777

Group type: COMPARATOR
Intervention: Banked donor milk or preterm formula as sole diet or supplement to mother's expressed breast milk in trial A
Number of subjects: 777

Group type: EXPERIMENTAL
Intervention: Term or preterm formula in trial B
Number of subjects: 777
Study: 203635

Group type: EXPERIMENTAL
Intervention: BRL 5907 (5 mg per day for three days)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 30888736

Group type: EXPERIMENTAL
Intervention: NeoVas sirolimus-eluting bioresorbable scaffold (BRS)
Number of subjects: 1103
Study: 28580708

Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (OXT) 24 IU
Number of subjects: 192

Group type: COMPARATOR
Intervention: Placebo (PLC)
Number of subjects: 192
Study: 25721787

Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH; 20mg)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study: 23685325

Group type: EXPERIMENTAL
Intervention: Mindful eating workshop
Number of subjects: 102

Group type: COMPARATOR
Intervention: Educational video (Control)
Number of subjects: 102
Study: 21300350

Group type: EXPERIMENTAL
Intervention: Fluvastatin (10mg daily for 30 days)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 19460446

Group type: EXPERIMENTAL
Intervention: Hypnosis
Number of subjects: 13

Group type: COMPARATOR
Intervention: Normal wakefulness
Number of subjects: 13
Study: 16721398

Group type: EXPERIMENTAL
Intervention: Low-fat cheese enriched with 2 g of plant stanols per day
Number of subjects: 67

Group type: COMPARATOR
Intervention: Control cheese with no plant stanols
Number of subjects: 67
Study: 15201248

Group type: EXPERIMENTAL
Intervention: 1 mg oral dose of oestradiol
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: 1 mg oestradiol orally/day for 12 weeks
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study: 11167171

Group type: EXPERIMENTAL
Intervention: isobaric mepivacaine 20 mg/ml
Number of subjects: 80

Group type: COMPARATOR
Intervention: isobaric lidocaine 20 mg/ml
Number of subjects: 80
Study: 9315790

Group type: EXPERIMENTAL
Intervention: Triamcinolone acetonide inhalation aerosol (TAA) 200 microg (1 puff bid)
Number of subjects: 285

Group type: EXPERIMENTAL
Intervention: Triamcinolone acetonide inhalation aerosol (TAA) 400 microg (2 puffs bid)
Number of subjects: 285

Group type: EXPERIMENTAL
Intervention: Triamcinolone acetonide inhalation aerosol (TAA) 800 microg (4 puffs bid)
Number of subjects: 285

Group type: EXPERIMENTAL
Intervention: Triamcinolone acetonide inhalation aerosol (TAA) 1600 microg (8 puffs bid)
Number of subjects: 285

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 285
Study: 8361220

Group type: COMPARATOR
Intervention: Cranial irradiation with 18Gy
Number of subjects: 994

Group type: COMPARATOR
Intervention: Cranial irradiation with 24Gy
Number of subjects: 994

Group type: EXPERIMENTAL
Intervention: Induction therapy with three drugs, CNS protection with cranial irradiation 18Gy or 24Gy, maintenance therapy for 120 weeks (GBTLI-80)
Number of subjects: 994

Group type: EXPERIMENTAL
Intervention: Induction therapy with three drugs, CNS protection with cranial irradiation 18Gy or 24Gy, continuous maintenance for 2 years (GBTLI-82)
Number of subjects: 994

Group type: EXPERIMENTAL
Intervention: No cranial radiation, CNS protection with triple intrathecal therapy, consolidation therapy with high dose ARA-C for high risk patients (GBTLI-85)
Number of subjects: 994
Study: 2940953

Group type: EXPERIMENTAL
Intervention: Cromolyn sodium (200 mg by spinhaler) + Atropine sulfate (2.0 mg by nebulizer)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Cromolyn sodium (200 mg) + Ipratropium bromide (200 micrograms)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Cromolyn sodium (200 mg)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Atropine sulfate (2.0 mg)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9

Group type: COMPARATOR
Intervention: Ipratropium bromide (200 micrograms)
Number of subjects: 9
Study: 31014520

Group type: EXPERIMENTAL
Intervention: Blood Coagulum (BC)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Bone Allograft (AL)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Bovine Bone (BB)
Number of subjects: 32
Study: 30104327

Group type: EXPERIMENTAL
Intervention: Interactive telephone reminder
Number of subjects: 629

Group type: EXPERIMENTAL
Intervention: Short message service reminder (SMS)
Number of subjects: 629

Group type: COMPARATOR
Intervention: Control (no additional interventions)
Number of subjects: 629
Study: 27436469

Group type: EXPERIMENTAL
Intervention: Enhanced therapy (doxycycline and ceftriaxone)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Standard therapy (benzathine penicillin G)
Number of subjects: 69
Study: 25193534

Group type: EXPERIMENTAL
Intervention: Low-dose UPA-CVR (1500 μg/day)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: High-dose UPA-CVR (2500 μg/day)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Levonorgestrel (LNG) 1.5 mg orally
Number of subjects: 55
Study: 22994618

Group type: EXPERIMENTAL
Intervention: Home-based physical therapy once a month for 6 months, along with educational support, counselling and audiovisual materials
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard care rehabilitation as prescribed by a physician and educational materials upon discharge from hospital
Number of subjects: 60
Study: 20353316

Group type: EXPERIMENTAL
Intervention: Behavior change counseling intervention (2 h workshop)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 35
Study: 18396455

Group type: EXPERIMENTAL
Intervention: Zonisamide (ZNS) 200 mg/day for 8 weeks
Number of subjects: 15
Study: 16317827

Group type: EXPERIMENTAL
Intervention: Roflumilast
Number of subjects: 0
Study: 12356154

Group type: EXPERIMENTAL
Intervention: CoStasis (collagen-based composite)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Collagen sponge with manual pressure (control)
Number of subjects: 53
Study: 10400099

Group type: EXPERIMENTAL
Intervention: 13C-octanoic acid breath test
Number of subjects: 28
Study: 8548959

Group type: EXPERIMENTAL
Intervention: Merocel nasal tampons
Number of subjects: 50

Group type: COMPARATOR
Intervention: BIPP (Bismuth Subnitrate and Iodoform Paste)
Number of subjects: 50
Study: 2293047

Group type: EXPERIMENTAL
Intervention: Transcranial Doppler ultrasonography after lumbar puncture
Number of subjects: 36

Group type: COMPARATOR
Intervention: Transcranial Doppler ultrasonography before lumbar puncture
Number of subjects: 36
Study: 7269016

Group type: EXPERIMENTAL
Intervention: Povidone-iodine enema (P.I.E.)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (not receiving P.I.E.)
Number of subjects: 40
Study: 29691649

Group type: EXPERIMENTAL
Intervention: Adaptive interference control training
Number of subjects: 88

Group type: COMPARATOR
Intervention: Active control condition
Number of subjects: 88
Study: 28343558

Group type: EXPERIMENTAL
Intervention: Simulator group (n=9)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Real patient group (n=9)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Overall score improvement (all trainees)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Simulator group (very unconfident trainees)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Patient group (very unconfident trainees)
Number of subjects: 18
Study: 26373569

Group type: EXPERIMENTAL
Intervention: Octreotide long-acting repeatable (LAR)
Number of subjects: 196
Study: 23635309

Group type: EXPERIMENTAL
Intervention: High Volume (HV) exercise (200-300 minutes/week)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Low Volume (LV) exercise (<150 minutes/week)
Number of subjects: 90
Study: 20615504

Group type: EXPERIMENTAL
Intervention: Tailored cardiac rehabilitation program
Number of subjects: 225

Group type: COMPARATOR
Intervention: Traditional cardiac rehabilitation program
Number of subjects: 225
Study: 19763700

Group type: EXPERIMENTAL
Intervention: Higher BMI (per 10 kg/m² increase)
Number of subjects: 238

Group type: EXPERIMENTAL
Intervention: Higher BMI (after adjustment for age and gender)
Number of subjects: 238
Study: 17338717

Group type: EXPERIMENTAL
Intervention: ICD therapy in patients with CKD
Number of subjects: 229

Group type: COMPARATOR
Intervention: ICD therapy in patients without CKD
Number of subjects: 229

Group type: EXPERIMENTAL
Intervention: CKD as a predictor of death
Number of subjects: 229

Group type: EXPERIMENTAL
Intervention: Reduction in creatinine clearance
Number of subjects: 229
Study: 15284015

Group type: EXPERIMENTAL
Intervention: 10.5 mg total dose (three vials of SALon)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: 17.5 mg total dose (five vials of SALon)
Number of subjects: 44
Study: 11876441

Group type: EXPERIMENTAL
Intervention: Tramadol 50 mg capsules
Number of subjects: 20

Group type: COMPARATOR
Intervention: Tramal 50 mg capsules (control)
Number of subjects: 20
Study: 9555559

Group type: EXPERIMENTAL
Intervention: Finasteride (Proscar)
Number of subjects: 182

Group type: COMPARATOR
Intervention: Ex-placebo group
Number of subjects: 182
Study: 7822587

Group type: EXPERIMENTAL
Intervention: Patients with a greater right-ear (left hemisphere) advantage
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Patients with a lower right-ear advantage
Number of subjects: 0

Group type: COMPARATOR
Intervention: Healthy control subjects
Number of subjects: 0
Study: 2893867

Group type: EXPERIMENTAL
Intervention: biosynthetic human growth hormone (BSHGH) 0.1 mg/kg daily for the first 7 postoperative days
Number of subjects: 11

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 11
Study: 29402675

Group type: EXPERIMENTAL
Intervention: Pay-by-month phones
Number of subjects: 81

Group type: COMPARATOR
Intervention: Gift card compensation
Number of subjects: 81
Study: 24934432

Group type: EXPERIMENTAL
Intervention: Expressive writing intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Neutral writing condition (control)
Number of subjects: 0
Study: 25507175

Group type: EXPERIMENTAL
Intervention: IDeg-flex
Number of subjects: 1180

Group type: COMPARATOR
Intervention: IDeg-evening
Number of subjects: 1180

Group type: COMPARATOR
Intervention: IGlar
Number of subjects: 1180
Study: 23036611

Group type: EXPERIMENTAL
Intervention: Perceived stress
Number of subjects: 621

Group type: EXPERIMENTAL
Intervention: Low levels of eating awareness
Number of subjects: 621

Group type: EXPERIMENTAL
Intervention: Overall perceived stress and BMI
Number of subjects: 621
Study: 20921837

Group type: EXPERIMENTAL
Intervention: Intrathecal bupivacaine 0.5% (15 mg), morphine 0.4 mg, and fentanyl 15 μg
Number of subjects: 40

Group type: COMPARATOR
Intervention: Intrathecal morphine 0.4 mg and fentanyl 15 μg
Number of subjects: 40
Study: 18522937

Group type: EXPERIMENTAL
Intervention: I.V. ropivacaine
Number of subjects: 19

Group type: COMPARATOR
Intervention: I.V. lidocaine
Number of subjects: 19
Study: 15916853

Group type: EXPERIMENTAL
Intervention: IL1B ‐31C/‐511T alleles and homozygotes in sporadic simple FS patients
Number of subjects: 229

Group type: COMPARATOR
Intervention: Control group (158 controls)
Number of subjects: 229
Study: 12693656

Group type: EXPERIMENTAL
Intervention: FloSeal (FS)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Thrombin-soaked gelatin foam
Number of subjects: 20
Study: 10482146

Group type: EXPERIMENTAL
Intervention: Aspirin plus cilostazol
Number of subjects: 490

Group type: COMPARATOR
Intervention: Aspirin plus ticlopidine
Number of subjects: 490
Study: 8928187

Group type: EXPERIMENTAL
Intervention: Synthetic human insulin infused at 40 mU/m2/min for 2 hr
Number of subjects: 17

Group type: COMPARATOR
Intervention: 10% xylitol infused at 100 ml/hr for 2 hr (control)
Number of subjects: 17
Study: 1824218

Group type: EXPERIMENTAL
Intervention: 2 g salt per day diet (Group I)
Number of subjects: 32

Group type: COMPARATOR
Intervention: 10 g salt per day diet (Group II)
Number of subjects: 32
Study: 6787909

Group type: EXPERIMENTAL
Intervention: Glucose-insulin-potassium (G-I-K) infusion (300 gm of glucose, 50 units of insulin, and 80 mEq of KCl per liter at a rate of 1.5 ml/kg/hr for 48 hours)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Conventional therapy (control group)
Number of subjects: 24
Study: 31881241

Group type: EXPERIMENTAL
Intervention: Selective Caries Removal (SCR)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Total Caries Removal (TCR)
Number of subjects: 120
Study: 30451318

Group type: EXPERIMENTAL
Intervention: Glycopyrronium tosylate (GT)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 44
Study: 30211991

Group type: EXPERIMENTAL
Intervention: Aged Garlic Extract (AGE)
Number of subjects: 151

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 151
Study: 27515154

Group type: EXPERIMENTAL
Intervention: Cholecalciferol (250,000 IU vitamin-D3)
Number of subjects: 218

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 218
Study: 24335748

Group type: EXPERIMENTAL
Intervention: ED treatment after 12 weeks
Number of subjects: 362

Group type: COMPARATOR
Intervention: Non-drug, run-in period (4 weeks)
Number of subjects: 362
Study: 22194025

Group type: EXPERIMENTAL
Intervention: BrainLAB® mask with custom made bite‐block (fixation S)
Number of subjects: 16

Group type: COMPARATOR
Intervention: BrainLAB® mask without custom made bite‐block (fixation A)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Homemade neck support with bite‐block (fixation B)
Number of subjects: 16
Study: 19111269

Group type: EXPERIMENTAL
Intervention: Innovative radiotherapy technology
Number of subjects: 0

Group type: COMPARATOR
Intervention: Historical examples of randomized trials
Number of subjects: 0
Study: 17326837

Group type: EXPERIMENTAL
Intervention: 5 pounds monetary incentive for completion of questionnaires
Number of subjects: 547

Group type: COMPARATOR
Intervention: No monetary incentive (historical control)
Number of subjects: 547
Study: 15197115

Group type: EXPERIMENTAL
Intervention: Tramadol (100 mg)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Famotidine (20 mg)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 30
Study: 11772834

Group type: EXPERIMENTAL
Intervention: Alkalinized lidocaine (Group LB)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Lidocaine (Group L)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Air Control (Group C)
Number of subjects: 75
Study: 9661598

Group type: EXPERIMENTAL
Intervention: Filter paper blood spot assay for IGF-I
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Filter paper blood spot assay for IGFBP-3
Number of subjects: 27

Group type: COMPARATOR
Intervention: Filter paper procedures
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Correlation of IGF-I and IGFBP-3 in paired plasma and dried blood spot extracts
Number of subjects: 27
Study: 8567794

Group type: EXPERIMENTAL
Intervention: i.v. immunoglobulins (Ig)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study: 2547617

Group type: EXPERIMENTAL
Intervention: Advice on dietary factors including reduction in total fat and increase in polyunsaturated fat intake
Number of subjects: 2033

Group type: EXPERIMENTAL
Intervention: Advice on increasing fatty fish intake
Number of subjects: 2033

Group type: EXPERIMENTAL
Intervention: Advice on increasing cereal fibre intake
Number of subjects: 2033

Group type: COMPARATOR
Intervention: No advice regarding dietary factors
Number of subjects: 2033
Study: 308283

Group type: EXPERIMENTAL
Intervention: Methylprednisolone (Solu-Medrol) before temporary cardiopulmonary bypass
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control group (no methylprednisolone)
Number of subjects: 150
Study: 31241527

Group type: EXPERIMENTAL
Intervention: Trunk stabilization exercise
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard hip muscle exercise (Control)
Number of subjects: 20
Study: 29296854

Group type: EXPERIMENTAL
Intervention: Prednisone
Number of subjects: 26

Group type: COMPARATOR
Intervention: Cyclosporine (CSA)
Number of subjects: 26
Study: 24506693

Group type: EXPERIMENTAL
Intervention: Amniotic membrane transplantation (AMT) combined with mitomycin C (MMC)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Conjunctival autograft (CA) combined with mitomycin C (MMC)
Number of subjects: 55
Study: 22673926

Group type: EXPERIMENTAL
Intervention: Oseltamivir (Tamiflu®) 75 mg single dose
Number of subjects: 30
Study: 22145462

Group type: EXPERIMENTAL
Intervention: Low Insulin Response Diet (LIR)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Conventional Diet (CD)
Number of subjects: 86